- Show all
- Abigail Coursolle
- Alejandra Pavisich
- Alejandra Pavisich
- Alexis Robles-Fradet
- Alicia Emanuel
- Amanda Avery
- Amy Chen
- Andy DiAntonio
- Arielle Linsey
- Brian Brooks
- Candace Gibson
- Carly Myers
- Cassandra LaRose
- Cat Duffy
- Catherine McKee
- Cathren Cohen
- Charlie Blodnieks
- Charly Gilfoil
- Cheyenne Peters
- Christina Piecora
- Corey Davis
- Dania Douglas
- Daniel Young
- David Machledt
- Deanna Hartog
- Elizabeth Edwards
- Elizabeth G. Taylor
- Emma Parker-Newton
- Eskedar Girmash
- Fabiola De Liban
- Georgesula Ziama
- Geron Gadd
- Hannah Eichner
- Hayley Penan
- Héctor Hernández-Delgado
- Ian McDonald
- Jane Perkins
- Jasmine Young
- Jennifer Lav
- Joe McLean
- Jules Lutaba
- Kally Xu
- Kasey Nichols
- Kavisha Prajapati
- Kimberly Lewis
- Leonardo Cuello
- lhigashi
- Liz McCaman Taylor
- Madeline Morcelle
- Mara Youdelman
- Margaret Okakpu
- Maya Levin
- Michelle Lilienfeld
- Michelle Yiu
- Miriam Delaney Heard
- Mizue Suito
- Priscilla Huang
- Rachel Holtzman
- Rolonda Donelson
- Sarah Grusin
- Sarah Somers
- Skyler Rosellini
- Susan Berke Fogel
- T. Nancy Lam
- veng
- Wayne Turner
- Zamir M. Brown
- Show all
- Alabama
- Alaska
- All United States
- Arizona
- Arkansas
- California
- Colorado
- Connecticut
- Delaware
- District of Columbia
- Florida
- Georgia
- Hawaii
- Idaho
- Illinois
- Indiana
- Iowa
- Kansas
- Kentucky
- Louisiana
- Maine
- Maryland
- Massachusetts
- Michigan
- Minnesota
- Mississippi
- Missouri
- Montana
- National
- Nebraska
- Nevada
- New Hampshire
- New Jersey
- New Mexico
- New York
- North Carolina
- North Dakota
- Ohio
- Oklahoma
- Oregon
- Pennsylvania
- Rhode Island
- South Carolina
- South Dakota
- Tennessee
- Texas
- Utah
- Vermont
- Virginia
- Washington
- West Virginia
- Wisconsin
- Wyoming
- June 15, 2021
State Approaches to Improving Reproductive and Sexual Health
Read moreNHeLP conducted a 50-state review of state Medicaid websites of COVID-19 related policies related to reproductive and sexual health care. This issue brief describes some of the temporary Medicaid and other health care policies and practices states put in place during the pandemic to facilitate the coverage and delivery…
- April 8, 2021
Post-Abortion Contraceptive Coverage in Medicaid
Read moreThis issue brief discusses how Medicaid allows coverage of family planning services during an abortion visit that is not covered by Medicaid. Family planning services and supplies is a mandatory Medicaid service and has been classified as a non-related service to an abortion. While the federal law is clear,…
- March 31, 2021
Making “Convenient Care” the Right Care for All: Improving State Oversight of Urgent Care Centers and Retail Health Clinics
Tess Solomon, Kelly Jo Popkin, Amy Chen, Lois Uttley, and Susannah Baruch Manual/Report, Article, GuideRead moreA growing number of health care consumers are turning to urgent care centers and retail health clinics, which have rapidly proliferated across the country in recent years and are sometimes referred to as “convenient care.” Urgent care centers have played a particularly critical role in meeting the high demand…
- December 17, 2020
Medicaid Coverage of Family Planning Services Delivered via Telehealth
Read moreThe COVID-19 public health emergency has shown the need to increase access to health services through telehealth, including for Medicaid beneficiaries. Almost nine months into the pandemic, millions of people have accessed services via telehealth. However, the need and desire for telehealth will persist after the public health emergency…
- December 3, 2020
NHeLP Comments on HHS Regulations Rule (aka SUNSET Rule)
Read moreIn the Regulations Rule, HHS seeks to retroactively impose a mandatory expiration date on an estimated 18,000 duly promulgated regulations. Even long-standing rules would be automatically rescinded unless they survive a complex process of assessment and review. Programs like Medicaid and the Children's Health Insurance Program (CHIP) could be…
- September 17, 2020
NHeLP comments on Approved Drug Products with Therapeutic Equivalence Evaluations (the “Orange Book”)
Read moreThe Orange Book is an important and informative drug resource for a range of stakeholders. In a request for comments, FDA seeks feedback on the types of people or entitles using the Orange Book, additional information and features to incorporate into the Orange Book, and therapeutic equivalence information. NHeLP…